Study: Zeng 2022, Frontiers in Immunology

Efficacy and Safety of Curcumin and Curcuma longa Extract in the Treatment of Arthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trial

Citation

Zeng L, Yang T, Yang K, Yu G et al (2022). Frontiers in Immunology. PubMed id 35935936.

Open on PubMed

Cards that cite this study (1)

Each card gives its own wording for who was tested, how and what was found.

  • Turmeric and curcumin supplements Tier B moderate

    B People with arthritis (osteoarthritis, rheumatoid, ankylosing spondylitis, juvenile arthritis, gout) in 29 randomised trials (n=2396)

    Systematic review and meta-analysis of curcumin and turmeric extract, 120 to 1,500 mg for 4 to 36 weeks.

    Curcumin and turmeric extract improved pain and inflammation markers in arthritis in the pooled trials and appeared safe. The authors warn the trials are low quality and few, and that the conclusions need careful interpretation.

    As recorded in this card: Zeng L, Yang T, Yang K, Yu G et al (2022), Frontiers in Immunology, [review]

    Note: Low quality trials. Ethnicity not reported in the abstract.

This is information, not medical advice. If you are worried, see a doctor or pharmacist. How we grade the evidence. All studies.